Navigation Links
Top Bristol-Myers Squibb Executive Joins Patton Boggs
Date:2/18/2010

WASHINGTON, Feb. 18 /PRNewswire-USNewswire/ -- Patton Boggs LLP has hired Dick Thompson, a top executive at Bristol-Myers Squibb with nearly four decades of public policy experience, to strengthen its hand in the healthcare and pharmaceutical sectors.

Mr. Thompson joins the firm as senior counsel in its Washington office where he will utilize his extensive experience with complex health and pharmaceutical policy issues to help clients navigate a challenging political environment.

"It is a major coup to have such a highly experienced and well-respected leader like Dick Thompson join the firm," said Stuart M. Pape, managing partner of the firm. "Our clients will benefit from his deep industry connections, significant government affairs prowess and experience as an executive at a major international powerhouse like Bristol-Myers Squibb."

Mr. Thompson, known as the "Dean" of the pharmaceutical industry corporate representatives, is a respected leader in the public policy and pharmaceutical industries. He spent the past decade as Bristol-Myers Squibb's senior vice president for policy and government affairs where he established and led a 45-member global staff.

As a member of the Bristol-Myers Squibb's operating committee, Mr. Thompson represented the company to key industry associations and managed the development of major public policy positions. At the time of his retirement in December 2009, Mr. Thompson had served as head of the Washington office for more than 26 years, longer than any current or former industry executive.

During his tenure, he worked to move the company to the top tier of advocacy in the pharmaceutical industry, pioneered a new international government affairs program and led the integration of the government affairs staff in the merger of the Bristol-Myers and Squibb companies.

"Patton Boggs has long been regarded as the premier public policy firm in the country, and I am excited to join such an exalted team," Mr. Thompson said. "I look forward to utilizing my experience at Bristol-Myers Squibb to help clients from the pharmaceutical and other industries achieve their strategic business and policy objectives."

Mr. Thompson spent nearly eight years working on Capitol Hill, including three years as Republican staff director and chief counsel to what is now known as the House Committee on Government Oversight and Reform.

Mr. Thompson moved to Washington in 1970 after serving two years in the U.S. Army, including a tour in Vietnam where he earned the rank of captain.

Mr. Thompson is active in many charitable and civic organizations. He is a vice chairman and trustee of Syracuse University, where he received his master's degree from the Maxwell School of Citizenship and Public Affairs. In addition, he has served as the president and a board member of the Carlton Club, chair of Ford Theatre's board of trustees and as chair of the governance committee and a member of the board of directors of Meridian International Center. He serves as a member of the Federal City Council.

Patton Boggs LLP

Based in Washington, D.C., Patton Boggs is a leader in public policy, litigation, and business law, and is well known for its deep bipartisan roots in the U.S. political arena. The firm's core practice areas are Public Policy and Regulatory, Litigation, Business, and Intellectual Property. With offices in New York, New Jersey, Dallas, Denver, Anchorage, Northern Virginia and internationally in Doha, Qatar and Abu Dhabi, United Arab Emirates, more than 600 lawyers and professionals provide comprehensive, practical and cost-effective legal counsel to clients around the globe. For more information, visit us at www.pattonboggs.com. To receive press releases from Patton Boggs, please contact Rebecca Carr at rcarr@pattonboggs.com.

SOURCE Patton Boggs LLP

RELATED LINKS
http://www.pattonboggs.com

'/>"/>

SOURCE Patton Boggs LLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe
2. Bristol-Myers Squibb, New Jersey Childrens Hospital Launch Center for Immune System Disorders & Infectious Diseases Including HIV/AIDS
3. Babson Executive Education Offers Bio-Pharma: Mastering the Business of Science
4. Encorium Re-Appoints Dr. Kai Lindevall as Chief Executive Officer and Appoints Current Director, Shahab Fatheazam, Chairman of the Board
5. Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position
6. Dr. Yahia Gawad, CEO of CardioGenics Holdings, Inc., Interviewed in MedTech Executive
7. Shu-Tung Li, Founder and CEO of Collagen Matrix, Inc. Honored as 2009 New Jersey Executive of the Year and Company Named Sixteenth Fastest Growing Company
8. Lilly CFO Derica Rice Assumes Expanded Responsibilities, Promoted to Executive Vice President
9. Cardinal Health Executives to Speak at Two Investor Events in January
10. New Executive Leadership and CEO Announced for BiPar Sciences
11. Ascension Orthopedics Hires Key Senior Executives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology:
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet ... product that was developed to enhance the health of felines. The formula is all-natural ... two main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews ...
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):